Mount Sinai Medical Center - New York — New York, New York

Mount Sinai Medical Center - New York is a clinical research site located in New York, New York, United States.

Crixeo Health Trust Score: 69/100 (FAIR). This profile has not yet been claimed by the site owner.

Mount Sinai Medical Center - New York has participated in 3 clinical trials with 2 currently active.

Therapeutic areas: Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Sponsors: AstraZeneca, Leap Therapeutics, Inc., Center for International Blood and Marrow Transplant Research.

Sponsor Feasibility Report

Trust Score: 69/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Medical Center - New York?

Mount Sinai Medical Center - New York has a Crixeo Trust Score of 69/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Medical Center - New York conducted?

Mount Sinai Medical Center - New York has 3 clinical trials on record, with 2 currently active. Their work covers Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV.

Is Mount Sinai Medical Center - New York accredited by Crixeo Health?

Mount Sinai Medical Center - New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mount Sinai Medical Center - New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.